Meeting Abstract


DOI :10.26650/JARHS2021-1133477   IUP :10.26650/JARHS2021-1133477    Full Text (PDF)

EXOSOMES – A NEW FRONTIER IN CANCER THERAPY

Sevgi Gezici

Exosomes, also called exosome vesicles (EcVs), contain DNA, RNA (including mRNA, miRNA, and ncRNA), proteins, lipid layer molecules, metabolic enzymes, signal transduction molecules, and other components and are produced in the endosomes of almost all cells, tissues, and body fluids. As exosomal cargoes, they play key roles in signaling pathways, immune regulation, cellular development, carcinogenesis, and homeostasis, providing a potential portal for cell-free drug delivery systems. Exosomal components that vary from cell-to-cell and organ-to-organ, are used to evaluate a biological response. Thus, the variation in the exosomal components makes them promising candidates for biomarkers for cancer detection and diagnosis. Moreover, the recent advances in medicine have revealed that exosomes are capable of crossing the blood-brain barrier and transporting drugs. A growing number of studies have been conducted to understand the therapeutic potential of exosomes in cancer. Because exosomes alter the local and systemic environment for cancer cell development, inhibiting their release is an important treatment strategy. In addition to the targeted use of exosomes, there are also treatment approaches in cancer therapy in which exosomes are used directly for therapeutic purposes. However, previous studies show that exosomebased therapy is very promising. Nevertheless, further research is needed to determine unique biomarkers for clinical application. Therefore, the emerging therapeutic and regulatory potentials of exosomes in the field of cancer research are highlighted through a comprehensive literature review.


PDF View

References

    Citations

    Copy and paste a formatted citation or use one of the options to export in your chosen format


    EXPORT



    APA

    Gezici, S. (2022). EXOSOMES – A NEW FRONTIER IN CANCER THERAPY. Journal of Advanced Research in Health Sciences, 5(1), 44-44. https://doi.org/10.26650/JARHS2021-1133477


    AMA

    Gezici S. EXOSOMES – A NEW FRONTIER IN CANCER THERAPY. Journal of Advanced Research in Health Sciences. 2022;5(1):44-44. https://doi.org/10.26650/JARHS2021-1133477


    ABNT

    Gezici, S. EXOSOMES – A NEW FRONTIER IN CANCER THERAPY. Journal of Advanced Research in Health Sciences, [Publisher Location], v. 5, n. 1, p. 44-44, 2022.


    Chicago: Author-Date Style

    Gezici, Sevgi,. 2022. “EXOSOMES – A NEW FRONTIER IN CANCER THERAPY.” Journal of Advanced Research in Health Sciences 5, no. 1: 44-44. https://doi.org/10.26650/JARHS2021-1133477


    Chicago: Humanities Style

    Gezici, Sevgi,. EXOSOMES – A NEW FRONTIER IN CANCER THERAPY.” Journal of Advanced Research in Health Sciences 5, no. 1 (Feb. 2024): 44-44. https://doi.org/10.26650/JARHS2021-1133477


    Harvard: Australian Style

    Gezici, S 2022, 'EXOSOMES – A NEW FRONTIER IN CANCER THERAPY', Journal of Advanced Research in Health Sciences, vol. 5, no. 1, pp. 44-44, viewed 24 Feb. 2024, https://doi.org/10.26650/JARHS2021-1133477


    Harvard: Author-Date Style

    Gezici, S. (2022) ‘EXOSOMES – A NEW FRONTIER IN CANCER THERAPY’, Journal of Advanced Research in Health Sciences, 5(1), pp. 44-44. https://doi.org/10.26650/JARHS2021-1133477 (24 Feb. 2024).


    MLA

    Gezici, Sevgi,. EXOSOMES – A NEW FRONTIER IN CANCER THERAPY.” Journal of Advanced Research in Health Sciences, vol. 5, no. 1, 2022, pp. 44-44. [Database Container], https://doi.org/10.26650/JARHS2021-1133477


    Vancouver

    Gezici S. EXOSOMES – A NEW FRONTIER IN CANCER THERAPY. Journal of Advanced Research in Health Sciences [Internet]. 24 Feb. 2024 [cited 24 Feb. 2024];5(1):44-44. Available from: https://doi.org/10.26650/JARHS2021-1133477 doi: 10.26650/JARHS2021-1133477


    ISNAD

    Gezici, Sevgi. EXOSOMES – A NEW FRONTIER IN CANCER THERAPY”. Journal of Advanced Research in Health Sciences 5/1 (Feb. 2024): 44-44. https://doi.org/10.26650/JARHS2021-1133477



    TIMELINE


    Published Online09.08.2022

    LICENCE


    Attribution-NonCommercial (CC BY-NC)

    This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


    SHARE




    Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.